Company news, press releases, and more. Follow this page for new exciting updates and more news on what is happening at CELLINK.
As part of the research call Prospekt 21, financed in part by a grant provided by KK Stiftelse, the group will work to develop diagnostic
The judges at SLAS Europe 2022, held in Dublin on May 24-27, granted the New Product Award to the BIO CELLX biodispenser. We are thrilled
Adding Allegro 3D to the portfolio enables BICO Bioprinting to strengthen its position as the global leader in providing 3D bioprinters. BICO has a robust
The leading 3D bioprinting company, CELLINK, has entered the most important distribution partnership in Latin America in 2022 with widely known supplier, CTR Scientific, to
During the collaboration CELLINK will provide expertise on biofabrication and bioink development with Zoan BioMed contributing their in-depth knowledge of coral growth characteristics and its
As part of BICO’s mission to reduce the impact due to organ shortages, CELLINK a part of BICO Bioprinting will now be able to provide
Addressing the gaps of organ shortages with a novel platform for the personalization of xenogeneic and 3D printed tissue scaffolds – an enormous opportunity for
The BIO CELLX is a first of its kind biodispensing platform used to automate 3D cell culture. By providing cell biologists with pre-validated protocols, the
CollPlant and CELLINK will explore the use of CELLINK’s next-generation high throughput extrusion bioprinters for the future commercial production of CollPlant’s regenerative breast implants, addressing
The Quantum X bio combines CELLINK’s bioprinting expertise with the engineering excellence of Nanoscribe to create a first-of-its-kind bioprinter Today, BICO companies CELLINK and Nanoscribe
Avijit Minocha
Head of Marketing
akm@bico.com
Send us an email by filling in the contact form here.
U.S.: +1 (833) 235-5465
EU: +46 31-12 87 00
India: +91 (0) 98808 58741
Japan: +81 (75)746-3032
Singapore: +65 8750 2284
